MED Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
$0.10
Past Year
$0.33
Growth Past 5yrs
-50.52%
Next Quarter
-$0.39
Estimate Next Year
-$43.21
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$16.50
(
25.09% Upside
)Mean Price Target
$16.50
(
25.09% Upside
)Lowest Price Target
$16.50
(
25.09% Upside
)Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
MED Earnings Per Share (EPS) History
According to financial reports, MED (NYSE: MED) reported an actual EPS of $0.1029 for the quarter ending on Nov 04, 2024, compared to an estimated $-0.28, resulting in a -136.75% surprise. In the prior quarter (Aug 05, 2024), MED recorded an actual EPS of $0.92 with a 155.56% surprise. See MED's full earnings history.
Earnings History
EPS Surprise Factor Analysis
MED has experienced notable EPS surprises, with the latest quarter ending Nov 04, 2024 showing a -136.75% miss. Previously, the quarter ending Aug 05, 2024 recorded a 155.56% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
Frequently Asked Questions
Is MED stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given MED stock an average recommendation of
Hold. 1 analysts have given their ratings
to MED out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
1 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$16.50 gives the stock implied upside
of roughly 25.09% over the next year or so.
What have analysts suggested for MED highest price target?
Analysts suggest MED's stock price would rise to a high of $16.50.
What is the lowest price target analysts expect for MED over the next year?
Within the next 12 months, analysts predict the MED stock price could move to $16.50.
What is the average target price for MED?
MED stock has an average analyst estimate of $16.50.
At its current price, how far is MED from its average target price?
MED shares are currently trading 25.09% above this price target.
What were MED’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $0.10 versus consensus estimates of -$0.28, and below the comparable year-ago quarter’s EPS of $2.12.
What are the current estimates for quarterly and annual earnings per share?
MED's forecasts by analysts estimating quarterly EPS at -$0.39 and -$43.21 for the whole year.
What has MED's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for MED in the next five years, compared to growth rates of -50.52% in the past five years.